Revvity, Inc. (NYSE:RVTY) Shares Bought by GAMMA Investing LLC

GAMMA Investing LLC increased its position in Revvity, Inc. (NYSE:RVTY - Free Report) by 15,023.0% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 287,035 shares of the company's stock after acquiring an additional 285,137 shares during the period. GAMMA Investing LLC owned approximately 0.24% of Revvity worth $30,368,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. T. Rowe Price Investment Management Inc. lifted its stake in Revvity by 16.7% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 20,761,308 shares of the company's stock valued at $2,317,170,000 after acquiring an additional 2,969,326 shares during the period. Vanguard Group Inc. raised its holdings in shares of Revvity by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 14,290,211 shares of the company's stock worth $1,594,930,000 after purchasing an additional 156,679 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in Revvity by 17.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 7,631,597 shares of the company's stock valued at $851,764,000 after purchasing an additional 1,151,821 shares during the period. Janus Henderson Group PLC lifted its position in Revvity by 0.4% during the fourth quarter. Janus Henderson Group PLC now owns 6,358,952 shares of the company's stock valued at $709,725,000 after purchasing an additional 23,650 shares during the period. Finally, EdgePoint Investment Group Inc. boosted its holdings in Revvity by 51.1% in the fourth quarter. EdgePoint Investment Group Inc. now owns 4,058,231 shares of the company's stock valued at $452,939,000 after purchasing an additional 1,372,456 shares during the last quarter. Institutional investors and hedge funds own 86.65% of the company's stock.

Analyst Ratings Changes

RVTY has been the subject of a number of recent research reports. Wells Fargo & Company reduced their price objective on Revvity from $130.00 to $102.00 and set an "equal weight" rating for the company in a research note on Thursday, April 17th. Wall Street Zen cut Revvity from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. UBS Group raised Revvity from a "neutral" rating to a "buy" rating and decreased their price target for the company from $145.00 to $115.00 in a report on Thursday, May 1st. Barclays lowered their price objective on Revvity from $140.00 to $110.00 and set an "overweight" rating on the stock in a research report on Thursday, April 10th. Finally, Robert W. Baird cut their target price on shares of Revvity from $127.00 to $125.00 and set an "outperform" rating for the company in a report on Tuesday, April 29th. Five investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $125.64.

Revvity Price Performance

NYSE RVTY traded up $1.49 on Friday, hitting $91.99. The company had a trading volume of 903,371 shares, compared to its average volume of 956,823. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. The company's fifty day moving average price is $93.51 and its 200-day moving average price is $107.43. The company has a market capitalization of $10.84 billion, a PE ratio of 41.63, a PEG ratio of 3.82 and a beta of 0.97. Revvity, Inc. has a 12-month low of $87.70 and a 12-month high of $129.50.

Revvity (NYSE:RVTY - Get Free Report) last announced its earnings results on Monday, April 28th. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. The business had revenue of $664.76 million for the quarter, compared to analyst estimates of $662.30 million. During the same quarter last year, the business earned $0.98 earnings per share. The company's revenue for the quarter was up 2.3% compared to the same quarter last year. As a group, analysts predict that Revvity, Inc. will post 4.94 earnings per share for the current year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 8th. Shareholders of record on Friday, July 18th will be paid a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, July 18th. This represents a $0.28 annualized dividend and a yield of 0.30%. Revvity's dividend payout ratio (DPR) is currently 11.91%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.